| 溶解性 | 78 mg/mL in DMSO <1 mg/mL in Water 78 mg/mL in Ethanol |
| 存贮条件 | 储存温度-20°C |
| 应用 | A CETP inhibitor |
| 产品介绍 | Dalcetrapib (JTT-705, RO4607381)是一种rhCETP抑制剂，IC50为0.2 μM，提高血浆中高密度脂蛋白（HDL）胆固醇。 |
| 备注 | Dalcetrapib (JTT-705) is a rhCETP inhibitor with IC50 of 0.2 μM that increases the plasma HDL cholesterol. Phase 3. |
| 生化机理 | Dalcetrapib is a CETP inhibitor for rhCETP with IC50 of 0.2 μM |
| 别名 | 达塞曲匹; CETP 抑制剂;JTT-705;RO-4607381;JTT705;JTT 705;RO 4607381;RO4607381;2-Methylpropanethioic acid S-[2-[1-(2-ethylbutyl)cyclohexylcarboxamido]phenyl] ester |
达塞曲匹
Dalcetrapib （订货以英文为准）
编号：D125851
CAS号：211513-37-0
分子式：C23H35NO2S
分子量：389.59
| 产品名称 | Dalcetrapib |
| 中文名称 | 达塞曲匹 |
| CAS号 | 211513-37-0 |
| 分子式（M.F.） | C23H35NO2S |
| 分子量（M.W.） | 389.59 |
| 储存条件 | -20°C储存 |
| 标识符号 | https://www.aladdin-e.com/images/ghs/ghs02.jpg,https://www.aladdin-e.com/images/ghs/ghs07.jpg |
| 信号词 | Danger |
| 危害声明 | H225-H302 + H332-H319 |
| 警示性声明 | P210-P305 + P351 + P338 |
| RTECS | UQ4431050 |
| WGK德国 | 2 |
| 闪点（摄氏） | 35.6 °F |
技术规格
| Background: | Non-catalytic subunit of the KPC complex that acts as E3 ubiquitin-protein ligase. Required for poly-ubiquitination and proteasome-mediated degradation of CDKN1B during G1 phase of the cell cycle. |
| Applications: | ELISA, IHC |
| Name of antibody: | UBAC1 |
| Immunogen: | Fusion protein of human UBAC1 |
| Full name: | UBA domain containing 1 |
| Synonyms: | KPC2; GBDR1; UBADC1 |
| SwissProt: | Q9BSL1 |
| ELISA Recommended dilution: | 5000-10000 |
| IHC positive control: | Human tonsil and Human colorectal cancer |
| IHC Recommend dilution: | 50-300 |
搜索质检报告(COA)
搜索MSDS
相关产品
党沛 
